2,3,7,8-tetrachlorodibenzo-p-dioxin delays palatal shelf elevation and suppresses Wnt5a and lymphoid enhancing-binding factor 1 signaling in developing palate

Cleft Palate-Craniofacial Journal

Volumn 52, Issue 1, 2015, Pages 54-61

  Hu, Xiao ^a,b   Gao, Jian Hua ^b   Liao, Yun Jun ^b   Tang, Shi Jie ^c   Lu, Feng ^b  

^a GUANGZHOU RED CROSS HOSPITAL   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Cleft palate; Lef 1; Wnt5a

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCING BINDING FACTOR 1; UNCLASSIFIED DRUG; WNT11 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; LYMPHOID ENHANCER FACTOR 1; POLYCHLORINATED DIBENZODIOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR POSTERIOR AXIS; ARTICLE; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; DOWN REGULATION; DRUG EXPOSURE; EMBRYO; FEMALE; MALE; MOLECULAR MECHANICS; MORPHOGENESIS; MOUSE; NONHUMAN; PALATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TERATOGENESIS; WNT SIGNALING PATHWAY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EMBRYOLOGY; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; TUNEL ASSAY; WNT SIGNALING;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CLEFT PALATE; IN SITU NICK-END LABELING; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICROSCOPY, ELECTRON, SCANNING; POLYCHLORINATED DIBENZODIOXINS; WNT SIGNALING PATHWAY;

EID: 84920697746     PISSN: 10556656     EISSN: 15451569     Source Type: Journal    
DOI: 10.1597/13-018     Document Type: Article

References (21)

1. Abbott BD. Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology. 1995;105:365-373.
2. Abbott BD. The etiology of cleft palate: a 50-year search for mechanistic and molecular understanding. Birth Defects Res B Dev Reprod Toxicol. 2010;89:266-274.
3. Allgeier SH, Lin TM, Vezina CM, Moore RW, Fritz WA, Chiu SY, Zhang C, Peterson RE. WNT5A selectively inhibits mouse ventral prostate development. Dev Biol. 2008;324:10-17.
4. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell. 2005;9:283-292.
5. Chiquet BT, Blanton SH, Burt A, Ma D, Stal S, Mulliken JB, Hecht JT. Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet. 2008;17:2212-2218.
6. Couture LA, Abbott BD, Birnbaum LS. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology. 1990;42:619-627.
7. Economou AD, Ohazama A, Porntaveetus T, Sharpe PT, Kondo S, Basson MA, Gritli-Linde A, Cobourne MT, Green JB. Periodic stripe formation by a Turing mechanism operating at growth zones in the mammalian palate. Nat Genet. 2012;44:348-351.
8. Gritli-Linde A. The etiopathogenesis of cleft lip and cleft palate: usefulness and caveats of mouse models. Curr Top Dev Biol. 2008;84:137-138.
9. He F, Xiong W, Yu X, Espinoza-Lewis R, Liu C, Gu S, Nishita M, Suzuki K, Yamada G, Minami Y, et al. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development. 2008;135:3871-3879.
10. Hilliard SA, Yu L, Gu S, Zhang Z, Chen YP. Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice. J Anat. 2005;207:655-667.
11. Juriloff DM, Harris MJ, Brown CJ. Unravelling the complex genetics of cleft lip in the mouse model. Mamm Genome. 2001;12:426-435.
12. Juriloff DM, Harris MJ,McMahon AP, Carroll TJ, Lidral AC. Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test. Birth Defects Res A Clin Mol Teratol. 2006;76:574-579.
13. Mathew LK, Sengupta SS, LaDu J, Andreasen EA, Tanguay RL. Crosstalk between AHR and Wnt signaling through R-Spondin1 impairs tissue regeneration in zebrafish. FASEB J. 2008;22:3087-3096.
14. Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006;25:7461-7468.
15. Niemann S, Zhao C, Pascu F, Stahl U, Aulepp U, Niswander L, Weber JL, Muller U. Homozygous WNT3 mutation causes tetraamelia in a large consanguineous family. Am J Hum Genet. 2004;74:558-563.
16. Person AD, Beiraghi S, Sieben CM, Hermanson S, Neumann AN, Robu ME, Schleiffarth JR, Billington CJ Jr, van Bokhoven H, Hoogeboom JM, et al. WNT5A mutations in patients with autosomal dominant Robinow syndrome. Dev Dyn. 2010;239:327-337.
17. Prochazkova J, Kabatkova M, Brvja V, Umannova L, Bernatik O, Kozubik A, Machala M, Vondracek J. The interplay of the aryl hydrocarbon receptor and b-catenin alters both AhR-dependent transcription and Wnt/b-catenin signaling in liver progenitors. Toxicol Sci. 2011;122:349-360.
18. Tamarin A, Boyde A. Facial and visceral arch development in the mouse embryo: a study by scanning electron microscopy. J Anat. 1977;124:563-580.
19. Thomae TL, Stevens EA, Bradfield CA. Transforming growth factorbeta3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlor-odibenzo-p-dioxin. J Biol Chem. 2005;280:12742-12746.
20. Tsang H, Cheung TY, Kodithuwakku SP, Chai J, Yeung WS, Wong CK, Lee KF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) suppresses spheroids attachment on endometrial epithelial cells through the down-regulation of the Wnt-signaling pathway. Reprod Toxicol. 2012;33:60-66.
21. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell. 2003;5:367-377.